A detailed history of Ifp Advisors, Inc transactions in Novavax Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 3,445 shares of NVAX stock, worth $27,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,445
Previous 3,045 13.14%
Holding current value
$27,766
Previous $14,000 207.14%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$3.89 - $20.97 $1,556 - $8,388
400 Added 13.14%
3,445 $43,000
Q3 2023

Oct 12, 2023

BUY
$6.81 - $9.74 $3,098 - $4,431
455 Added 17.57%
3,045 $22,000
Q2 2023

Aug 04, 2023

BUY
$6.67 - $9.52 $3,028 - $4,322
454 Added 21.25%
2,590 $19,000
Q1 2023

Apr 18, 2023

SELL
$5.76 - $12.48 $27,982 - $60,627
-4,858 Reduced 69.46%
2,136 $14,000
Q4 2022

Feb 07, 2023

BUY
$8.86 - $25.04 $47,498 - $134,239
5,361 Added 328.29%
6,994 $52,000
Q3 2022

Nov 08, 2022

BUY
$18.2 - $76.12 $24,169 - $101,087
1,328 Added 435.41%
1,633 $20,000
Q2 2022

Sep 06, 2022

BUY
$36.28 - $75.29 $11,065 - $22,963
305 New
305 $9,000
Q2 2022

Aug 12, 2022

SELL
$36.28 - $75.29 $11,065 - $22,963
-305 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$69.73 - $142.9 $6,903 - $14,147
99 Added 48.06%
305 $22,000
Q1 2022

Aug 08, 2022

BUY
$69.73 - $142.9 $836 - $1,714
12 Added 6.19%
206 $15,000
Q4 2021

Jan 12, 2022

SELL
$134.56 - $217.97 $6,997 - $11,334
-52 Reduced 21.14%
194 $27,000
Q3 2021

Oct 06, 2021

SELL
$177.8 - $270.58 $13,157 - $20,022
-74 Reduced 23.13%
246 $52,000
Q2 2021

Jul 13, 2021

BUY
$121.0 - $257.67 $3,388 - $7,214
28 Added 9.59%
320 $69,000
Q1 2021

Apr 30, 2021

SELL
$112.98 - $319.93 $4,971 - $14,076
-44 Reduced 13.1%
292 $54,000
Q4 2020

Jan 25, 2021

BUY
$78.74 - $139.5 $7,480 - $13,252
95 Added 39.42%
336 $36,000
Q3 2020

Oct 29, 2020

BUY
$79.44 - $178.51 $19,145 - $43,020
241 New
241 $26,000
Q2 2020

Aug 05, 2020

SELL
$13.86 - $83.61 $180 - $1,086
-13 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$3.93 - $16.0 $51 - $208
13 New
13 $0

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.